Dosimetry for radiopharmaceutical therapy: From measurement to dose justification
Why dosimetry for radiopharmaceutical therapy needs more than absorbed dose. How BED, radiation dosimetry &…
Hunter Stephens, PhD2026 年 7 月 7 日
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
Certara2026 年 6 月 26 日
Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies
Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…
Certara2026 年 6 月 23 日
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study
Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…
Certara2026 年 6 月 23 日
Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab
Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…
Certara2026 年 6 月 23 日
Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development
Discover how a mechanistic quantitative systems pharmacology (QSP) model predicts mast cell inhibition and depletion…
Certara2026 年 6 月 16 日
Population Pharmacokinetic Modeling to Predict Absorbed and Biologically Effective Dose for Radioligand Therapies
Explore how population PK modeling predicts absorbed dose and biologically effective dose for radioligand therapies.
Certara2026 年 6 月 9 日
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-Bodnar2026 年 5 月 28 日
